Keyphrases
Treatment Response
100%
Attention Deficit Hyperactivity Disorder
100%
Gene Polymorphism
100%
Dopamine Serotonin
100%
Methylphenidate Treatment
100%
Methylphenidate
75%
Parent Report
75%
Dopamine Transporter
50%
3′-untranslated Region (3′-UTR)
50%
Serotonin Transporter Promoter
50%
CHRNA4
50%
Logistic Regression
25%
Genotype
25%
Polymorphism
25%
Population-based
25%
Nicotinic Acetylcholine Receptor (nAChR)
25%
Promoter Region
25%
DRD4
25%
Dopamine Receptor
25%
Potential Risk Factors
25%
Allelic Variation
25%
5-HTTLPR
25%
Sampling Methods
25%
High Power
25%
Attention-deficit Hyperactivity Disorder Symptoms
25%
Response-adapted
25%
Yes-no Questions
25%
Exon 3
25%
Variable number Tandem Repeat
25%
Pharmacogenetic Study
25%
Functional Polymorphism
25%
DAT1
25%
SLC6A4
25%
Alpha4
25%
Neuroscience
Attention Deficit Hyperactivity Disorder
100%
DNA Polymorphism
100%
Serotonin
100%
Methylphenidate
100%
Variable Number Tandem Repeat
60%
Promoter Region
40%
Dopamine Transporter
40%
Serotonin Transporter
40%
Untranslated Region
40%
CHRNA4
40%
Nicotinic Acetylcholine Receptor
20%
Exon
20%
Dopamine Receptor
20%